Table 3.
Characteristics of patients who received gamma knife surgery.
| Patient | BMI (SDS) | Presenting symptom | Ki-67 index (%) | Maximum tumor diameter (mm) | PRL at diagnosis (ng/mL) | Immediate postoperative PRL level (ng/mL) | Pre GKS PRL (ng/mL) | Post GKS PRL (ng/mL) | Tumor volume (mm3) | Prescription dose (Gy) |
|---|---|---|---|---|---|---|---|---|---|---|
| P7 | 2.1 | Gal | 4.16 | 20 | 185 | 33.6 | 81.09 | 58.9 | 1,021 | 15 |
| P13 | 1.4 | Gal | 3.00 | 10 | 78 | 2.9 | 64.9 | 29.4 | 231 | 25 |
| P15 | 1.32 | HA | 4.0 | 25 | 3,950 | 278 | 527.4 | 437.1 | 5,900 | 24 |
BMI, body mass index; SDS, standard deviation score; PRL, prolactin; GKS, gamma knife surgery; TSA, transsphenoidal approach; GAL, galactorrhea; HA, headache.